INTERNATIONAL PATENT: CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD., 石药集团巨石生物制药有限公司 FILES APPLICATION FOR "ANTIBODY OR ANTIBODY FRAGMENT WHICH BIND TO TROP2 AND DRUG CONJUGATE COMPRISING SAME"

GENEVA, July 28 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development Zone,Shijiazhuang, Hebei 050027), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2025/072237) for "ANTIBODY OR ANTIBODY FRAGMENT WHICH BIND TO TROP2, AND DRUG CONJUGATE COMPRISING SAME" on Jan 14, 2025. With publication no. WO/2025/152920, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (...